Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

被引：154
|
作者：
Enting, RH
Demopoulos, A
DeAngelis, LM
Abrey, LE
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[2] Univ Groningen Hosp, Dept Neurol, Groningen, Netherlands
来源：
NEUROLOGY | 2004年 / 63卷 / 05期
关键词：
D O I：
10.1212/01.WNL.0000137050.43114.42
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors evaluated the efficacy of a combination of rituximab and temozolomide for recurrent or refractory primary CNS lymphoma (PCNSL). Fifteen patients with a median age of 69 years had a 53% objective response rate with acceptable toxicity. Median overall survival is 14 months and median progression free survival of responding patients is 7.7 months. This combination merits further study and provides a reasonable therapeutic alternative for older patients with progressive PCNSL.
引用
收藏
页码：901 / 903
页数：3
相关论文
共 50 条
  • [31] Salvage therapy for primary central nervous system lymphoma with 90Y-Ibritumomab and Temozolomide
    Pitini, Vincenzo
    Baldari, Sergio
    Altavilla, Giuseppe
    Arrigo, Carmela
    Naro, Claudia
    Perniciaro, Francesca
    JOURNAL OF NEURO-ONCOLOGY, 2007, 83 (03) : 291 - 293
  • [32] Salvage therapy for primary central nervous system lymphoma with 90Y-Ibritumomab and Temozolomide
    Vincenzo Pitini
    Sergio Baldari
    Giuseppe Altavilla
    Carmela Arrigo
    Claudia Naro
    Francesca Perniciaro
    Journal of Neuro-Oncology, 2007, 83 : 291 - 293
  • [33] Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
    Cho, Min-Seok
    Kim, Jae Yong
    Jung, Seung-Yeon
    Ahn, Seo-Yeon
    Song, Ga Young
    Yang, Deok-Hwan
    BLOOD RESEARCH, 2016, 51 (04) : 285 - 287
  • [34] Radiation As an Effective Salvage Therapy for Secondary CNS Lymphoma
    Milgrom, S. A.
    Pinnix, C. C.
    Sheu, T.
    Qiao, W.
    Fowler, N.
    Westin, J.
    Nastoupil, L.
    Hagemeister, F.
    Oki, Y.
    Fanale, M. A.
    Fayad, L.
    Lee, H.
    Hosing, C.
    Nieto, Y.
    Shpall, E. J.
    Dabaja, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E432 - E433
  • [35] Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series
    Chamberlain, Marc C.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (01) : 155 - 162
  • [36] Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series
    Marc C. Chamberlain
    Journal of Neuro-Oncology, 2014, 118 : 155 - 162
  • [37] LENALIDOMIDE MONOTHERAPY AS SALVAGE TREATMENT FOR RECURRENT PRIMARY CNS LYMPHOMA
    Houillier, Caroline
    Choquet, Sylvain
    Touitou, Valerie
    Martin-Duverneuil, Nadine
    Navarro, Soledad
    Mokhtari, Karima
    Soussain, Carole
    Hoang-Xuan, Khe
    NEUROLOGY, 2015, 84 (03) : 325 - 326
  • [38] Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma
    Milgrom, Sarah A.
    Pinnix, Chelsea C.
    Chi, T. Linda
    Vu, Thinh H.
    Gunther, Jillian R.
    Sheu, Tommy
    Fowler, Nathan
    Westin, Jason R.
    Nastoupil, Loretta J.
    Oki, Yasuhiro
    Fayad, Luis E.
    Neelapu, Sattva
    Rodriguez, Maria Alma
    Hagemeister, Frederick B.
    Fanale, Michelle A.
    Lee, Hun J.
    Hosing, Chitra
    Ahmed, Sairah
    Nieto, Yago
    Shpall, Elizabeth J.
    Dabaja, Bouthaina S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1146 - 1154
  • [39] INTRAOCULAR LYMPHOMA DEVELOPED AFTER SALVAGE CHEMOTHERAPY FOR RECURRENT PRIMARY CNS LYMPHOMA AND PROMISING THERAPY-A CASE REPORT
    Fu, Beverly Dan
    Kong, Xiao-Tang
    Bota, Daniela A.
    NEURO-ONCOLOGY, 2011, 13 : 49 - 50
  • [40] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
    David Ritchie
    Nature Clinical Practice Oncology, 2007, 4 : 402 - 403
12345